Biofilm causes decreased production of interferon-gamma

Journal of the American Society of Nephrology

Volumn 7, Issue 6, 1996, Pages 877-882

  Dasgupta, Mrinal K ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Biofilm bacteria; Interferon gamma; Peritoneal dialysis; Peritonitis; Staphylococcus epidermidis

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BIOFILM; CASE REPORT; FEMALE; HUMAN; HYPOTHESIS; MACROPHAGE ACTIVATION; MALE; NATURAL KILLER CELL; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; T LYMPHOCYTE ACTIVATION;

EID: 0030367936     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bernadini J, Holley JL, Johnston JR, Perlutter JA, Piraino B: An analysis of ten year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1991;36:29-34.
2. Lewis S, Holmes CJ: Host defense mechanism in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1991;11:14-21.
3. Vas SI. Peritonitis. In: Nolph KD, Ed. Peritoneal Dialysis. Dordrecht: Kluwer Academic Publishers; 1988:261-280.
4. Dasgupta MK, Bettcher KB, Ulan RA, et al.: Relationship of adherent bacterial biofilms to peritonitis in chronic ambulatory peritoneal dialysis. Perit Dial Bull 1987;7: 168-173.
5. Pirano B, Bernadini J, Sorkin M: Catheter infections as a factor in the transfer of continuous ambulatory peritoneal dialysis patients to hemodialysis. Am J Kidney Dis 1989;13:365-369.
6. Verbrugh HA, Keane WF, Hoidal JF, Freiberg MR, Elliott GR Peterson PK: Peritoneal macrophages and opsonins: Antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 1983;147:1018-1029.
7. McGreggor SJ, Brock JH, Briggs JD, Junor B Jr: Bactericidal activity of peritoneal macrophages from CAPD patients. Nephrol Dial Transplant 1987;2:104-108.
8. Churchill DN, Taylor DW, Vas SI, et al.: Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multicenter randomized clinical trial comparing the Y-connector disinfectant system to standard systems. Perit Dial Int 1989;9:159-163.
9. Dasgupta MK, Fox S, Gagnon D, et al. Significant reduction of peritonitis rate by the use of twin-bag system in a Canadian regional CAPD program. In: Khanna R, Nolph KD, Prowant BF, Twadorski ZJ, Oreopoulos DG, Eds. Advances in Peritoneal Dialysis. Vol. 8. Toronto: University of Toronto Press; 1992:223-226.
10. Kieman L, Kliger A, Gorban-Brennan N, et al.: Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 1995;5:1835-1838.
11. Nathan CF, Murray HW, Weibe ME, Rubin BY: Identification of interferon-γ as the cytokine that activates human macrophage oxidative metabolism and microbicidal activity. J Exp Med 1983;158:670-689.
12. Bancroft GJ, Schriber RD, Bosma GC, Bosma MJ, Unanue ER: A T-cell independent mechanism of macrophage activation by interferon-γ. J Immunol 1987;139: 1104-1107.
13. Dasgupta MK, Costerton JW: Significance of biofilm-adherent bacterial microcolonies on Tenckhoff catheters of CAPD patients. Blood Purif 1989;7:144-155.
14. Read RR, Eberwein P, Dasgupta MK, et al.: Peritonitis in peritoneal dialysis: Bacterial colonization by biofilm spread along the catheter surface. Kidney Int 1989;35: 614-621.
15. Dasgupta MK, Ulan RA, Bettcher KB, et al. Effect of exit site infection and peritonitis on the distribution of biofilm-encased adherent bacterial microcolonies on Tenckhoff catheters in patients undergoing continuous ambulatory peritoneal dialysis. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, Eds. Advances in Peritoneal Dialysis. Vol. 6. Toronto: University of Toronto Press; 1986:102-109.
16. Lamperi S, Carrozzi S: Suppressor resident macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis. Nephron 1986;44:219-225.
17. Lamperi S, Carrozzi S: Interferon-γ as an in vitro enhancing factor of peritoneal macrophage detectivity of bactericidal activity during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1988;11:225-230.
18. Dasgupta MK, Larabie M, Halloran PF: Interferon-gamma levels in peritoneal dialysis effluents: Relation to peritonitis. Kidney Int 1994;46:475-481.
19. Dasgupta MK, Lam K, Ulan RA, et al.: An extracorporeal model of biofilm-adherent bacterial microcolony colonization (BABM) for the study of peritonitis in CAPD. Am J Nephrol 1988;8:118-122.
20. Dasgupta MK, Ward K, Noble PA, Larabie M, Costerton JW: Development of bacterial biofilms on SILASTIC™ catheter materials in peritoneal dialysis fluid. Am J Kidney Dis 1994;23:709-716.
21. Lamperi S, Carrozzi S: Immunological defenses in CAPD. Blood Purif 1989;7:126-143.
22. Costerton JW, Cheng KJ, Geesey GG, et al.: Bacterial biofilms in nature and disease. Ann Rev Microbiol 1987; 41:435-464.
23. Evans R, Holmes E: Effect of vancomycin hydrochloride on Staphylococcal epidermidis biofilm associated with silicone elastometer. Antimicrob Agents Chemother 1987;31:889-894.
24. Anwar H, Dasgupta MK, Lam K, Costerton JW: Tobramycin resistance of mucoid Pseudomonas aeuroginosa biofilm grown under iron limitations. J Antimicrob Chemother 1989;24:647-655.
25. Obst G, Gagnon R, Harris AD, Prentice J, Richards GK: The activity of rifampin and analogs against Staphylococcus epidermidis biofilms in a CAPD environment model. Am J Nephrol 1989;9:414-420.
26. Dasgupta MK, Kowalewska-Grochowska K, Costerton JW: Biofilm and peritonitis in peritoneal dialysis. Perit Dial Int 1993;13[Suppl]:S322-S325.